Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.26 - $0.62 $1,531 - $3,652
5,891 Added 164.92%
9,463 $4,000
Q3 2023

Nov 09, 2023

SELL
$0.4 - $1.39 $322 - $1,120
-806 Reduced 18.41%
3,572 $1,000
Q2 2023

Aug 11, 2023

SELL
$1.07 - $1.55 $11,307 - $16,380
-10,568 Reduced 70.71%
4,378 $5,000
Q1 2023

May 12, 2023

SELL
$0.42 - $1.4 $1,956 - $6,521
-4,658 Reduced 23.76%
14,946 $17,000
Q4 2022

Feb 08, 2023

BUY
$0.31 - $8.8 $4,961 - $140,835
16,004 Added 444.56%
19,604 $8,000
Q2 2022

Aug 10, 2022

SELL
$0.63 - $1.22 $990 - $1,919
-1,573 Reduced 30.41%
3,600 $2,000
Q1 2022

May 16, 2022

BUY
$0.99 - $2.44 $1,557 - $3,838
1,573 Added 43.69%
5,173 $6,000
Q4 2021

Feb 14, 2022

SELL
$2.18 - $3.93 $3,254 - $5,867
-1,493 Reduced 29.31%
3,600 $8,000
Q3 2021

Nov 15, 2021

SELL
$2.71 - $4.35 $6,766 - $10,861
-2,497 Reduced 32.9%
5,093 $15,000
Q2 2021

Aug 13, 2021

SELL
$2.94 - $4.75 $1,852 - $2,992
-630 Reduced 7.66%
7,590 $30,000
Q1 2021

May 12, 2021

SELL
$3.99 - $5.53 $6,328 - $8,770
-1,586 Reduced 16.17%
8,220 $36,000
Q4 2020

Feb 11, 2021

BUY
$2.99 - $5.79 $11,580 - $22,424
3,873 Added 65.28%
9,806 $38,000
Q3 2020

Nov 12, 2020

SELL
$4.79 - $9.1 $8,741 - $16,607
-1,825 Reduced 23.52%
5,933 $29,000
Q2 2020

Jul 31, 2020

SELL
$3.61 - $11.84 $13,876 - $45,512
-3,844 Reduced 33.13%
7,758 $56,000
Q1 2020

May 01, 2020

SELL
$2.56 - $6.14 $32,844 - $78,776
-12,830 Reduced 52.51%
11,602 $49,000
Q4 2019

Feb 14, 2020

BUY
$5.78 - $8.11 $69,729 - $97,839
12,064 Added 97.54%
24,432 $145,000
Q3 2019

Nov 14, 2019

BUY
$6.55 - $9.36 $45,522 - $65,051
6,950 Added 128.28%
12,368 $102,000
Q2 2019

Aug 14, 2019

BUY
$5.92 - $9.47 $31,802 - $50,872
5,372 Added 11678.26%
5,418 $51,000
Q1 2019

May 14, 2019

SELL
$4.12 - $7.23 $786 - $1,380
-191 Reduced 80.59%
46 $0
Q4 2018

Feb 14, 2019

BUY
$3.65 - $5.54 $865 - $1,312
237 New
237 $1,000

Others Institutions Holding BSGM

About BioSig Technologies, Inc.


  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $60.1M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.